TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer

Type: Retraction
Notice date: 5/17/2021 0:00
Journal: Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Publisher: American Society of Clinical Oncology
Notice DOI: 10.1200/jco.21.00752
Original paper DOI: 10.1200/jco.2018.78.7986

Reasons